CEA-Leti receives $1.3M to support fluorescent imaging agent

07/8/2013 | BioOptics World

Bpifrance's Strategic Industrial Innovation program awarded CEA-Leti $1.3 million to support the preclinical development of fluorescent imaging agent LipImage 815. The imaging agent delivers a fluorescent substance via lipid nanoparticles to detect liver cancer cells in the early stages of the disease.

View Full Article in:

BioOptics World

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President of Medicare
UPMC Health Plan
Pittsburgh, PA
Actuary
NTA Life
Addison, TX
National Affairs Analyst
Verisk Analytics
Jersey City, NJ